KLTO Klotho Neurosciences, Inc.
USHealthcareAs of 2026-03-16 15:59
Why KLTO matters now
Klotho Neurosciences, Inc. (KLTO) is a US stock in Healthcare. The latest InvestLog snapshot shows $0.38 with -7.10% on the session and $20.1M in market capitalization; recent performance reads 1-month -7.10% and YTD +31.83%.
The latest financial table shown here is Q3 2025, with revenue of $0.00, net income of $-2.9M, and EPS of $-0.05. Investors can compare that operating picture with valuation signals such as P/E unavailable and FCF yield -27.9%.
The latest indexable market news headline is "Klotho Neurosciences (NASDAQ:KLTO) and Xenetic Biosciences (NASDAQ:XBIO) Head to Head Contrast" from Defense World.
Additional event context on this page matters because recent insider activity includes SINKULE JOSEPH filing A-Award. These signals are research inputs, not a recommendation.
Valuation
P/E (TTM)
—
PEG
—
P/B
2.22
P/S
0.00
EV/EBITDA
-1.94
DCF Value
$-0.01
FCF Yield
-27.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-137.6%
ROA
-110.0%
ROIC
-75.1%
Financials
| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $0.00 | $-2.9M | $-0.05 |
| Q2 2025 | $0.00 | $-4.1M | $-0.12 |
| Q1 2025 | $0.00 | $-2.2M | $-0.08 |
| Q4 2024 | $0.00 | $-2.1M | $-0.08 |
Trading Activity
Insider Trades
Related Stocks
Latest News
Company Info
Sector
Healthcare
Industry
Biotechnology
Country
US
Exchange
—
Beta
2.23
Klotho Neurosciences, Inc. operates as a biopharmaceutical enterprise focused on devising medical treatments for various conditions, including cancer, cardiovascular ailments, and neurodegenerative disorders. Their leading gene therapy assets encompass AMI-101, which is designed for the management or prevention of Alzheimer's disease, and AMI-202, aimed at treating or averting amyotrophic lateral sclerosis. Formerly known as Anew Medical, Inc., the company underwent a name change to Klotho Neurosciences, Inc. in September 2024. The firm's main office is situated in Omaha, Nebraska.